Approved · Waiver · decided in 25 days, 12 Oct 2026
Monarch Alternative Capital LP and General Atlantic are acquiring joint control of US NewCo LLC, holding the Loparex operating group. This equity acquisition is part of a financial restructuring and recapitalisation of Loparex, a manufacturer of release liner and technical film.
The transaction involves the acquisition of joint control over US NewCo LLC, an entity to be established (the Target ), that will at closing own, directly or indirectly, all of the issued and outstanding equity interests in the entities comprising the Loparex operating group ( Loparex ) by entities and funds affiliated with Monarch Alternative Capital LP ( Monarch ) and by funds managed and advised by affiliates of GASC APF, L.P. (together with its affiliated investment funds GA and, together with Monarch, the Acquirers ) (the Acquisition ). The Acquisition forms part of a broader financial restructuring of Loparex's capital structure, involving a refinancing and recapitalisation of substantially all of Loparex's outstanding funded indebtedness and equity. On completion, funds affiliated with Monarch and GA will indirectly hold equity interests in the Target. Monarch is a global credit and real estate investment firm with approximately $17 billion in assets under management, with offices in New York, Florida and London. GA is a global growth investor with more than four decades of experience providing capital and strategic support for over 520 growth companies. GA manages approximately USD $129.9 billion in assets under management as of 30 June 2026 with more than 900 professionals in 20 countries across 5 regions. Loparex is a manufacturer and provider of release liner and technical film, headquartered in the USA.